National Heart, Lung, and Blood Institute; Notice of Meeting, 65909-65910 [05-21657]

Download as PDF Federal Register / Vol. 70, No. 210 / Tuesday, November 1, 2005 / Notices represented and a short description of the oral presentation. Only one representative of an organization may be allowed to present oral comments. Both printed and electronic copies are requested for the record. In addition, any interested person may file written comments with the committee. All written comments must be received by November 7, 2005 and should be sent via email to nsabb@od.nih.gov with ‘‘NSABB Public Comment’’ as the subject line or by regular mail to 6705 Rockledge Drive, Suite 750, Bethesda, MD 20892, Attention Allison Chamberlain. The statement should include the name, address, telephone number and, when applicable, the business or professional affiliation of the interested person: Dated: October 20, 2005. Anthony M. Coelho, Jr., Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–21661 Filed 10–31–05; 8:45 am] BILLING CODE 4140-01-M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel. RFA: CA06–502 ‘‘AIDS Malignancy Clinical Trials Consortium.’’ Date: November 30, 2005. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Ramada Inn Rockville, 1775 Rockville Pike, Rockville, MD 20852. Contact Person: Joyce C. Pegues, PhD., Scientific Review Administrator, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Blvd. 7149, Bethesda, MD 20892. 301/594–1286. peguesj@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and VerDate Aug<31>2005 15:39 Oct 31, 2005 Jkt 208001 Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: October 20, 2005. Anthony M. Coelho, Jr., Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–21646 Filed 10–31–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES 65909 Grp., Division of Extramural Affairs/Section Chief, 6701 Rockledge Drive, Room 7194, Bethesda, MD 20892, 301/435–0288. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: October 20, 2005. Anthony M. Coelho, Jr., Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–21656 Filed 10–31–05; 8:45 am] BILLING CODE 4140–01–M National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Closed Meetings DEPARTMENT OF HEALTH AND HUMAN SERVICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. National Institutes of Health Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel Review of Research Project (R01) Applications Date: November 30, 2005. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Loews Annapolis Hotel, 126 West Street, Annapolis, MD 21401. Contact Person: Katherine M. Malinda, PhD, Scientific Review Administrator, Review Branch, Division of Extramural Affairs, National Heart, Lung, and Blood Institute, National Institutes of Health, 6701 Rockledge Drive, Room 7198, Bethesda, MD 20892, 301/435–0297. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel Review of Research Project (RO1) Applications Date: November 30, 2005. Time: 2 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Building 31, 31 Center Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Patricia A. Haggerty, PhD, Scientific Review Administrator, National Heart, Lung, and Blood Institute/NIH, Clinical Studies & Training Studies Rev. PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 National Heart, Lung, and Blood Institute; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the Sleep Disorders Research Advisory Board. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting: Name of Committee: Sleep Disorders Research Advisory Board. Date: December 6, 2005. Time: 8:30 a.m. to 5 p.m. Agenda: To discuss sleep research and education priorities and programs. Place: National Institutes of Health, Natcher Building, Conference Room D, Bethesda, MD 20892. Contact Person: Carl E Hunt, MD, Director, National Center on Sleep Disorders Research, National Heart, Lung, and Blood Institute, National Institutes of Health, 6705 Rockledge Drive, Room 6022, Bethesda, MD 20892, 301/ 435–0199. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. This statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance into the building by non-governmental employees. Persons without a government I.D. will need to show a photo I.D. and signin at the security desk upon entering the building. Information is also available on the Institute’s/Center’s home page: https:// www.nhlbi.nih.gov/meetings/index.htm, where an agenda and any additional E:\FR\FM\01NON1.SGM 01NON1 65910 Federal Register / Vol. 70, No. 210 / Tuesday, November 1, 2005 / Notices Place: Eisenhower Inn and Conference Center, 2634 Emmittsburg Road, Gettysburg, PA 17325. Contact Person: Claire Kelso, Intramural Program Specialist, Division of Intramural Research, Office of the Director, National Human Genome Research Institute, 50 South Drive, Building 50, Room 5222, Bethesda, MD 20892–8002, (301) 435–5802. (Catalogue of Federal Domestic Assistance Program No. 93.172, Human Genome Research, National Institutes of Health, HHS) Education; 93.894, Resources and Manpower Development in the Environmental Health Sciences; 93.113, Biological Response to Environmental Health Hazards; 93.114, Applied Toxicological Research and Testing, National Institutes of Health, HHS) Dated: October 20, 2005. Anthony M. Coelho, Jr., Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–21666 Filed 10–31–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4140–01–M National Institutes of Health National Institutes of Health DEPARTMENT OF HEALTH AND HUMAN SERVICES National Human Genome Research Institute; Notice of Meeting National Institutes of Health information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: October 20, 2005. Anthony M. Coelho, Jr., Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–21657 Filed 10–31–05; 8:45 am] BILLING CODE 4140–01–M Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the Board of Scientific Counselors, National Human Genome Research Institute. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended for the review, discussion, and evaluation of individual intramural programs and projects conducted by the National Human Genome Research Institute, including consideration of personnel qualifications and performance, and the competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Board of Scientific Counselors, National Human Genome Research Institute. Date: November 6–8, 2005. Open: November 6, 2005, 6:30 p.m. to 8 p.m. Agenda: To discuss matters of program relevance. Place: Eisenhower Inn and Conference Center, 2634 Emmittsburg Road, Gettysburg, PA 17325. Closed: November 6, 2005, 8 p.m. to Adjournment on November 8, 2005. Agenda: To review and evaluate personnel qualifications and performance, and competence of individual investigators. VerDate Aug<31>2005 15:39 Oct 31, 2005 Jkt 208001 National Institute of Environmental Health Sciences; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Environmental Health Sciences Review Committee. Date: November 9–10, 2005. Time: 8:30 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Hawthorne Suites Hotel, 300 Meredith Drive, Research Triangle Park, NC 27713. Contact Person: Linda K. Bass, PhD, Scientific Review Administrator, Nat’l Institute of Environmental Health Sciences, P.O. Box 12233, MD EC–24, Research Triangle Park, NC 27709, (919) 541–1307. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.115, Biometry and Risk Estimation—Health Risks from Environmental Exposures; 93.142, NIEHS Hazardous Waste Worker Health and Safety Training; 93.143, NIEHS Superfund Hazardous Substances—Basic Research and PO 00000 Frm 00034 Fmt 4703 Sfmt 4703 Dated: October 24, 2005. Anthony M. Coelho, Jr., Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–21647 Filed 10–31–05; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institute of Mental Health; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Mental Health Special Emphasis Panel, Bipolar Disorder Psychobiology. Date: November 11, 2005. Time: 2 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Christopher S Sarampote, PhD, Scientific Review Administrator, Division of Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., Room 6148, MSC 9608, Bethesda, MD 20892– 9608, 301–443–1959, csarampo@mail.nih.gov. Name of Committee: National Institute of Mental Health Special Emphasis Panel, ASCEND Collaborative R01s. Date: November 17, 2005. Time: 12 p.m. to 2 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Tracy Waldeck, PhD, Scientific Review Administrator, Division of E:\FR\FM\01NON1.SGM 01NON1

Agencies

[Federal Register Volume 70, Number 210 (Tuesday, November 1, 2005)]
[Notices]
[Pages 65909-65910]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-21657]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the Sleep Disorders Research Advisory Board.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting:

    Name of Committee: Sleep Disorders Research Advisory Board.
    Date: December 6, 2005.
    Time: 8:30 a.m. to 5 p.m.
    Agenda: To discuss sleep research and education priorities and 
programs.
    Place: National Institutes of Health, Natcher Building, 
Conference Room D, Bethesda, MD 20892.
    Contact Person: Carl E Hunt, MD, Director, National Center on 
Sleep Disorders Research, National Heart, Lung, and Blood Institute, 
National Institutes of Health, 6705 Rockledge Drive, Room 6022, 
Bethesda, MD 20892, 301/435-0199.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. This statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance into the building by non-governmental 
employees. Persons without a government I.D. will need to show a 
photo I.D. and sign-in at the security desk upon entering the 
building.
    Information is also available on the Institute's/Center's home 
page: https://www.nhlbi.nih.gov/meetings/index.htm, where an agenda 
and any additional

[[Page 65910]]

information for the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: October 20, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-21657 Filed 10-31-05; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.